David A. Solomon

Active 1974–2025

147
Papers
23,498
Citations
86
h-index
146
i10-index

Citations

Citations per year for David A. Solomon1976: 1 citations1977: 2 citations1979: 1 citations1981: 2 citations1987: 1 citations1990: 2 citations1991: 2 citations1992: 1 citations1993: 12 citations1994: 11 citations1995: 8 citations1996: 15 citations1997: 20 citations1998: 23 citations1999: 48 citations2000: 48 citations2001: 61 citations2002: 75 citations2003: 115 citations2004: 143 citations2005: 147 citations2006: 191 citations2007: 173 citations2008: 198 citations2009: 165 citations2010: 172 citations2011: 160 citations2012: 191 citations2013: 207 citations2014: 192 citations2015: 170 citations2016: 171 citations2017: 158 citations2018: 143 citations2019: 553 citations2020: 636 citations2021: 608 citations2022: 584 citations2023: 437 citations2024: 757 citations2025: 327 citations2026: 12 citations1978: no citations, so this year is not shown1980: no citations, so this year is not shown1982–1986: no citations, so these years are not shown1988–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,955 citing papers, 31.3% of this breakdownUnited Kingdom: 645 citing papers, 6.8% of this breakdownGermany: 616 citing papers, 6.5% of this breakdownCanada: 540 citing papers, 5.7% of this breakdownChina: 532 citing papers, 5.6% of this breakdownItaly: 442 citing papers, 4.7% of this breakdownFrance: 335 citing papers, 3.6% of this breakdownNetherlands: 310 citing papers, 3.3% of this breakdownAustralia: 302 citing papers, 3.2% of this breakdownSpain: 288 citing papers, 3.1% of this breakdownSwitzerland: 215 citing papers, 2.3% of this breakdownJapan: 213 citing papers, 2.3% of this breakdown
0%31.3%Other 21.6%

Fields

  • Medicine63.5%
  • Biochemistry, Genetics and Molecular Biology14.5%
  • Psychology7.1%
  • Computer Science7%
  • Neuroscience4.6%
  • Immunology and Microbiology1%
  • Other2.3%

Topics

  • Glioma Diagnosis and Treatment7.8%
  • Bipolar Disorder and Treatment6.9%
  • Treatment of Major Depression3.7%
  • Schizophrenia research and treatment3.2%
  • Tryptophan and brain disorders1.9%
  • Epigenetics and DNA Methylation1.9%
  • Other74.6%

Coauthors

All papers

Open in search
  1. A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets

    Authors: , , , , , , , , , , , , - Nature Cancer 2022 cited by 331

  2. Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2024 cited by 219

  3. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joanna J. Phillips, David A. Solomon, J Costello, Michael McDermott, Jeremy N. Rich, David R. Raleigh - Nature Genetics 2022 cited by 302

  4. The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder

    Authors: , , , , , , , , - Archives of General Psychiatry 2002 cited by 2,097

  5. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sameer Agnihotri, Adam Resnick, Brian R. Rood, Jessica Chew, Jacob S. Young, Lauren Boreta, Steve Braunstein, Jessica Schulte, Nicholas Butowski, Sandro Santagata, David Spetzler, Nancy Ann Oberheim Bush, Javier Villanueva-Meyer, James P. Chandler, David A. Solomon, Leland Rogers, Stephanie L. Pugh, Minesh P. Mehta, Penny K. Sneed, Mitchel S. Berger, Craig Horbinski, Michael McDermott, Arie Perry, Wenya Linda Bi, Akash J. Patel, Felix Sahm, Stephen T. Magill, David R. Raleigh - Nature Medicine 2023 cited by 106

  6. cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Weller, Valerie A. White, David W. Ellison - Brain Pathology 2020 cited by 534

  7. Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Uwe Kordes, David E. Kram, Matija Snuderl, Leslie Bridges, Andrew Martin, Lawrence J. Doey, Safa Al‐Sarraj, Christopher Chandler, Bassel Zebian, Claire Cairns, Rachael Natrajan, Jessica K.R. Boult, Simon P. Robinson, Martin Sill, Ira J. Dunkel, Stephen W. Gilheeney, Marc K. Rosenblum, Debbie Hughes, Paula Proszek, Tobey J. MacDonald, Matthias Preusser, Christine Haberler, Irene Slavc, Roger J. Packer, Ho‐Keung Ng, Shani Caspi, Mara Popović, Barbara Faganel Kotnik, Matthew D. Wood, Lissa Baird, Monika A. Davare, David A. Solomon, Thale Kristin Olsen, Petter Brandal, Michael Farrell, Jane Cryan, Michael Capra, Michael Karremann, Jens Schittenhelm, Martin U. Schuhmann, Martin Ebinger, Winand N.M. Dinjens, Kornelius Kerl, Simone Hettmer, Torsten Pietsch, Felipe Andreiuolo, Pablo Hernáiz Driever, Andrey Korshunov, Lotte Hiddingh, Barbara C. Worst, Dominik Sturm, Marc Zuckermann, Olaf Witt, Tabitha Bloom, Clare Mitchell, Evelina Miele, Giovanna Stefania Colafati, Francesca Diomedi‐Camassei, Simon Bailey, Andrew S. Moore, Tim Hassall, Stephen P. Lowis, Maria Tsoli, Mark J. Cowley, David S. Ziegler, Matthias A. Karajannis, Kristian Aquilina, Darren Hargrave, Fernando Carceller, Lynley V. Marshall and 14 more - Cancer Discovery 2020 cited by 278

  8. The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS Genetics 2014 cited by 453

  9. Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma

    Authors: , , , , , , - Neuro-Oncology Advances 2022 cited by 72

  10. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Péter Hauser, Nada Jabado, Young‐Shin Ra, Karel Zitterbart, Suyash Shringarpure, Francisco M. De La Vega, Carlos D. Bustamante, Ho‐Keung Ng, Arie Perry, Tobey J. MacDonald, Pablo Hernáiz Driever, Anne Bendel, Daniel C. Bowers, Geoffrey McCowage, Murali Chintagumpala, Richard J. Cohn, Tim Hassall, Gudrun Fleischhack, Tone Eggen, Finn Wesenberg, Maria Feychting, Birgitta Lannering, Joachim Schüz, Christoffer Johansen, Tina Veje Andersen, Martin Röösli, Claudia E. Kuehni, Michael A. Grotzer, Kristina Kjærheim, Camelia Maria Monoranu, Tenley C. Archer, Elizabeth S. Duke, Scott L. Pomeroy, Shelagh Redmond, Stephan Frank, David Sumerauer, Wolfram Scheurlen, Marina Ryzhova, Till Milde, Christian P. Kratz, David Samuel, Jinghui Zhang, David A. Solomon, Marco A. Marra, Roland Eils, Claus R. Bartram, Katja von Hoff, Stefan Rutkowski, Vijay Ramaswamy, Richard J. Gilbertson, Andrey Korshunov, Michael D. Taylor, Peter Lichter, David Malkin, Amar Gajjar, Jan O. Korbel, Stefan M. Pfister - The Lancet Oncology 2018 cited by 394

  11. Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas

    Authors: , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2021 cited by 120

  12. Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma

    Authors: , , , , , , , , , , , , , , , , , - Nature Medicine 2014 cited by 485

  13. Multiple Recurrences of Major Depressive Disorder

    Authors: , , , , , , , , , , - American Journal of Psychiatry 2000 cited by 836

  14. A Prospective Investigation of the Natural History of the Long-term Weekly Symptomatic Status of Bipolar II Disorder

    Authors: , , , , , , , , - Archives of General Psychiatry 2003 cited by 1,240

  15. PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications

    Authors: , , , , , , , , , , , , , , - Neuro-Oncology 2022 cited by 79

  16. Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection

    Authors: , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2010 cited by 381

  17. A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFR

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Jones, Felix Sahm - Neuro-Oncology 2020 cited by 126

  18. Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution

    Authors: , , , , , , , , , , , , , , , , , , - Nature Genetics 2024 cited by 55

  19. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2023 cited by 34

  20. Diffuse Midline Gliomas with Histone H3‐K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations

    Authors: , , , , , , - Brain Pathology 2015 cited by 445

  21. Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts

    Authors: , , , , , , , , - Cancer Research 2010 cited by 308

  22. Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults

    Authors: , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology Advances 2020 cited by 128

  23. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2016 cited by 233

  24. A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancers

    Authors: , , , , - Nature Communications 2019 cited by 111